Press release summary
Genedata has launched an electronic lab notebook embedded in its biopharmaceutical research and development platform. The company said the ELN connects experimental context with structured records for molecules, samples, process parameters, assays and analytical results rather than operating as a separate documentation system.
The new capability uses Genedata’s existing data model to keep experiment records tied to a candidate’s development history. It is intended to support biologics and other complex modalities, including antibody-drug conjugates, bispecifics, cell and gene therapies and peptides. The platform also brings together LIMS, sample management, registration and laboratory workflow execution, with connections to instruments, robotics and external laboratories, contract research organizations and contract development and manufacturing organizations.
For laboratory informatics teams, a shared data model can reduce manual transfers and help preserve lineage as work moves from experimental design through analysis and process development. It may also make records easier to search, reuse and prepare for automation or artificial intelligence applications. The practical value will depend on implementation, data governance and integration quality, but the launch reflects a broader move toward combining ELN and LIMS functions around a continuous, traceable scientific record.
Original source: Genedata, Oct. 28, 2026.
Leave a Reply